Table 3 |
|||||
|
Mean ± SEM of the eight health categories of SF-36 |
|||||
| Pre |
Post |
Follow-up1 |
Follow-up2 |
Follow-up3 |
|
|
|
|||||
| PF |
39.8 ± 3.6 |
39.8 ± 3.7 |
43.5 ± 4.8 |
44.1 ± 4.8 |
24.0 ± 9.9 |
| RP |
10.5 ± 3.8 |
12.9 ± 3.8 |
13.2 ± 2.6 |
13.6 ± 3.4 |
10.0 ± 6.1 |
| BP |
19.1 ± 2.0 |
22.0 ± 2.6 |
23.3 ± 3.7 |
27.9 ± 2.2 |
17.4 ± 4.0 |
| GH |
42.5 ± 2.7 |
42.2 ± 2.5 |
36.1 ± 1.9 |
44.6 ± 3.6 |
38.4 ± 2.9 |
| VT |
28.9 ± 2.5 |
31.8 ± 2.7 |
34.1 ± 3.2 |
37.1 ± 3.5 |
37.0 ± 8.5 |
| SF |
40.3 ± 4.2 |
42.2 ± 4.1 |
46.3 ± 5.6 |
45.5 ± 6.6 |
32.5 ± 10.2 |
| RE |
35.5 ± 7.3 |
48.3 ± 7.1 |
49.0 ± 8.9 |
66.7 ± 8.9* |
41.7 ± 18.8 |
| MH |
46.8 ± 3.6 |
53.8 ± 3.2 |
55.3 ± 4.1 |
56.7 ± 4.1 |
48.0 ± 10.7 |
|
|
|||||
|
PF Physical Functioning; RP Role-Physical; BP Bodily Pain; GH General Health; VT Vitality; SF Social Functioning; RE Role-Emotional; MH Mental Health. *Significantly different from pre (p = 0.043). |
|||||
|
Joos et al. Journal of Negative Results in BioMedicine 2004 3:1 doi:10.1186/1477-5751-3-1 |
|||||
